Mr. Massimiliano Cesarini MSEng
Sales Director, Romaco
Massimiliano Cesarini holds a Master Degree in Mechanical Engineering from the University of Bologna. After a research period at the University of California he started his professional career in the energy generation field before moving to Comecer Group in the 2009 where he held positions as Project Manager first, Product Manager and finally as Global Sales Manager for the Pharma&ATMP Division. In January 2021 he moved to Romaco Group where he has taken the role of Sales Director with responsibility of the sales and BD for the Italian brands of the group which are Promatic and Macofar. Member of the ISPE since 2009, he is currently part of the Leadership team of the Sterile Product Processing Community of Practice.
Appearances
Speakers
Scientific Fellow, Janssen Pharmaceutica IncHead of Personalized Medicine Business Unit, LonzaAssociate Director Process Engineering, Regenerative Medicine, United TherapeuticsMassimiliano Cesarini, MSEngSales Director, Romaco
DateMarch 17, 2021Devices and Decontamination—Overcoming Challenges | Aseptic products are oftentimes a component part of a Combination Product. These aseptically filled present technical challenges that will be addressed in this session. Additionally, manufacturers are often tasked with utilizing legacy equipment…Session Leader
Keith W. Weseli, CPIPCommissioning and Qualification Project Director, Stevanato GroupSpeakers
Massimiliano Cesarini, MSEngSales Director, RomacoKen Nagai, MBADirector, New Business Development, Airex Co., Ltd.- DateNovember 5, 2020Roads for CAR-T: Strategies for Cell Based ATMPs | With a small number of approved cell therapies/ ex-vivo gene therapies and with those approved therapies reaching small patient populations there is not a proven strategy for successful large-scale commercial manufacturing…
Speakers
Scientific Fellow, Janssen Pharmaceutica IncHead of Personalized Medicine Business Unit, LonzaAssociate Director Process Engineering, Regenerative Medicine, United TherapeuticsMassimiliano Cesarini, MSEngSales Director, Romaco 
DateMarch 6, 2023Annex 1, the European Union’s revised GMP requirements for the manufacturing of sterile medicinal products will take effect on 25 August 2023. As the document will also be adopted by PIC/S and WHO, the requirements become global…Session Leader
Director Aseptic Processing SME, Sanofi Pasteur – SwiftwaterSpeakers
Sr. Fellow - Aseptic and Sterile Products, Vertical Market Leader, CRBMassimiliano Cesarini, MSEngSales Director, RomacoSenior Consultant Aseptic Processing & Containment, SKAN AGSen. Director Pharma Excellence, Syntegon Technology GmbHVice President Vetter Development Service External Affairs, Vetter Pharma Fertigung GmbH & Co KG
DateMarch 6, 2023Contamination Control Strategy is a key concept in the new Annex 1, but contamination prevention is not new to the industry. It covers all aspects of aseptic processes, starting with the selection of equipment, its qualification and routine production…Session Leader
Vice President Vetter Development Service External Affairs, Vetter Pharma Fertigung GmbH & Co KGSpeakers
Massimiliano Cesarini, MSEngSales Director, RomacoManager International Business Department, Airex Co., Ltd.Ken Nagai, MBADirector, New Business Development, Airex Co., Ltd.Chief Process Engineer, Genesis AEC
